Company / Current Liabilities
Gossamer Bio, Inc. Current Liabilities History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$63.4M
FY2025
5-year range
$39.9M / $63.4M
FY2021-FY2025
Trend
+40.9%
vs FY2024
Sector context
#125 of 213
Health Care
What the data says
At $63M, Gossamer Bio, Inc.'s current liabilities ranks #89 of 213 in the Health Care sector. Increased from $52M to $63M over the past 2 years.
Based on SEC 10-K filings.
$63M in FY2025 with a 5-year CAGR of +10.4%.
Increased from $52M to $63M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +10.4%
- 10-Year CAGR
- -
Sector benchmark
#89 of 213 in Health CareTop 41% of 213This company $63.4M Sector average $1.6B
▼
-96.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.4%, indicating consistent growth.
- In FY2025, current liabilities increased 40.9% year-over-year.
- Ranks #125 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $63.4M | +40.9% |
| FY2024 | $45.0M | -12.8% |
| FY2023 | $51.6M | +4.8% |
| FY2022 | $49.2M | +23.5% |
| FY2021 | $39.9M | +3.1% |
| FY2020 | $38.6M | +4.7% |
| FY2019 | $36.9M | +81.0% |
| FY2018 | $20.4M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026